During placement of an interscalene block, the patient becomes hypotensive, bradycardic, and cyanotic. The most likely cause is

During placement of an interscalene block, the patient becomes hypotensive, bradycardic, and cyanotic. The most likely cause is

• A. Vertebral artery injection
• B. Carotid artery injection
• C. Phrenic nerve blockade
• D. Total spinal

Answer: (D)

When a patient experiences sudden hypotension, bradycardia, and cyanosis during an interscalene block, the most likely explanation is total spinal anesthesia from inadvertent spread of local anesthetic into the intrathecal space. Reaching the subarachnoid space produces a high neuraxial block that blocks sympathetic outflow and the cardioaccelerator fibers, causing profound vasodilation and a slow heart rate, along with respiratory muscle paralysis that leads to hypoventilation and hypoxemia (hence the cyanosis). This combination is characteristic of a high or total spinal and fits the rapid, severe cardiovascular and respiratory compromise seen here. Other scenarios, like phrenic nerve blockade, would mainly cause diaphragmatic paralysis and dyspnea but not the marked hypotension and bradycardia. Injection into the vertebral or carotid arteries could cause cerebral or systemic toxicity with different manifestations (such as focal neurologic deficits or seizures) rather than the rapid cardiovascular collapse and hypoxemia described.

When a patient experiences sudden hypotension, bradycardia, and cyanosis during an interscalene block, the most likely explanation is total spinal anesthesia from inadvertent spread of local anesthetic into the intrathecal space. Reaching the subarachnoid space produces a high neuraxial block that blocks sympathetic outflow and the cardioaccelerator fibers, causing profound vasodilation and a slow heart rate, along with respiratory muscle paralysis that leads to hypoventilation and hypoxemia (hence the cyanosis). This combination is characteristic of a high or total spinal and fits the rapid, severe cardiovascular and respiratory compromise seen here.

Other scenarios, like phrenic nerve blockade, would mainly cause diaphragmatic paralysis and dyspnea but not the marked hypotension and bradycardia. Injection into the vertebral or carotid arteries could cause cerebral or systemic toxicity with different manifestations (such as focal neurologic deficits or seizures) rather than the rapid cardiovascular collapse and hypoxemia described.